Denosumab regimens in the treatment of giant cell tumor of bone: A systematic review with meta-analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

577

Figures (1-2)

131

Tables (1-3)

109

Sum=844

Publishing Process of This Article

Item

Count

Browse

Download

Sum=84

Mar 18, 2025 (publication date) through May 12, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Orthop. Mar 18, 2025; 16(3): 102520
Published online Mar 18, 2025. doi: 10.5312/wjo.v16.i3.102520

Table 3 Overall demographic characteristics

Total participants included across all studies	n = 1742
Total males included across all studies	834 (48.2%)
Total females included across all studies	896 (51.8%)
Mean age of participants	35 years
Minimum age of participants	13 years
Maximum age of participants	81 years

Citation: Barreto BG, Santili C, Guedes A, Moreira FD, Paz CLD. Denosumab regimens in the treatment of giant cell tumor of bone: A systematic review with meta-analysis. World J Orthop 2025; 16(3): 102520
URL: https://www.wjgnet.com/2218-5836/full/v16/i3/102520.htm
DOI: https://dx.doi.org/10.5312/wjo.v16.i3.102520